WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: TARGETED LYMPHOMA CONSORTIUM (TLC)

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on TARGETED LYMPHOMA CONSORTIUM (TLC)

Mark Identification

Proof of use for TARGETED LYMPHOMA CONSORTIUM (TLC)

We do not have any records of a proof of use for TARGETED LYMPHOMA CONSORTIUM (TLC) at this moment.

Click here to add a proof of use for TARGETED LYMPHOMA CONSORTIUM (TLC)

Possible trademark infringements of TARGETED LYMPHOMA CONSORTIUM (TLC)

Basic Information about TARGETED LYMPHOMA CONSORTIUM (TLC)

Serial Number
86330094
Filing Date
07 Jul 2014
Registration Number
4695291
Registration Date
03 Mar 2015
Mark Drawing Code
4

Classifications

Declare the trademark use of TARGETED LYMPHOMA CONSORTIUM (TLC) on the blockchain with WikiTrademarks.io.

First use of TARGETED LYMPHOMA CONSORTIUM (TLC) anywhere
TARGETED LYMPHOMA CONSORTIUM (TLC) was first used on 09 Aug 2013 for the primary classification of goods and services, international, 035 (Advertising and business)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
2
International Code
035
US Codes
100; 101; 102
First use of TARGETED LYMPHOMA CONSORTIUM (TLC) anywhere
TARGETED LYMPHOMA CONSORTIUM (TLC) was first used on 09 Aug 2013 for the primary classification of goods and services, international, 036 (Insurance and financial)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
2
International Code
036
US Codes
100; 101; 102

Who owns TARGETED LYMPHOMA CONSORTIUM (TLC)?

Correspondent

JEANNE M. HEFFERNAN
KIRKLAND & ELLIS LLP
601 LEXINGTON AVE FL 35
NEW YORK, NY 10022-4643

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on TARGETED LYMPHOMA CONSORTIUM (TLC)